McKesson Corporation (MCK)
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MCK stock chart
Technical analysisKey statistics
All statistics- Market cap
- $123.47B
- P/E (TTM)
- 27.58
- Forward P/E
- 20.39
- EPS (TTM)
- $38.77
- Dividend yield
- 0.32% ($3.40)
- Ex-dividend date
- Sep 1, 2026
- 52-week range
- 723.68 – 1,121.50
- Day range
- 1,067.43 – 1,088.14
- Volume / Avg
- 869.45K / 790.59K
- Beta
- —
- Shares outstanding
- 115.46M
52-week range
MCK stock today
McKesson (MCK) closed at $1,069.43 on Nov 20, up 0.68% (+$7.27), versus the S&P 500's 3.70% decline. Shares are 4.6% below their 52-week high of $1,121.50, set on Nov 5, 2026 and 47.8% above the 52-week low of $723.68, near the top of the past year's range. MCK is up 30.4% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 23.5%.
At 27.6x trailing earnings, McKesson trades above the peer-group median of 18.9x. Its forward P/E of 20.4x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. McKesson pays an annual dividend of $3.40 per share, a 0.32% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About McKesson
Company profileMcKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- CEO
- Mr. Brian S. Tyler Ph.D.
- Headquarters
- Irving, TX
- Employees
- 41,600
- Website
- mckesson.com
Financial highlights
Full financialsIn fiscal 2026, McKesson generated $403.43 billion in revenue, up 12.4% from fiscal 2025, its 13th consecutive year of revenue growth. Net income was $4.76 billion (+44.5% year over year), for a net margin of 1.2% versus a median of 0.9% in the prior 5 years. Gross margin was 3.6% (down from 3.7%) and operating margin 1.5%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $403.43B | $359.05B | $308.95B | $276.71B | $263.97B |
| Growth | +12.36% | +16.22% | +11.65% | +4.83% | +10.80% |
| Net income | $4.76B | $3.29B | $3.00B | $3.56B | $1.11B |
| EPS (diluted) | $38.38 | $25.72 | $22.39 | $25.03 | $7.23 |
Analyst forecast
ForecastConsensus (16 analysts)
buy
Avg. price target
$1,161.07+8.57%
- Strong buy 3
- Buy 10
- Hold 3
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $10.44 vs $10.69
- Surprise
- -2.34%
Dividends
Dividend history- Annual dividend
- $3.40
- Dividend yield
- 0.32%
- Last payment
- $0.94
- Ex-dividend date
- Sep 1, 2026
MCK news
All MCK news- IWF, MCK, LMT, NOW: ETF Outflow AlertNasdaqIWF, MCK, LMT, NOW
- Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a BetNasdaq
- Beat the Market the Zacks Way: Vera Bradley, Herc, Visa in FocusNasdaqAMT, V, WMT, MCK
- McKesson: Slower FY2028 Revenue Growth Makes Today's Premium Less AttractiveSeeking Alpha
- Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending StockNasdaq
- 3 Reasons Why Growth Investors Shouldn't Overlook McKesson (MCK)Nasdaq
- IWF, MA, MCK, TT: ETF Inflow AlertNasdaqIWF, MA, MCK, TT
- McKesson Consensus Price Target Raised 10% to $1,157.23Nasdaq
McKesson peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CORCencora Inc. | 339.09 | -0.63% | $64.71B | vs MCK |
| CAHCardinal Health Inc. | 272.81 | +0.17% | $63.06B | vs MCK |
| HLFHerbalife Ltd. | 15.53 | -0.26% | $1.63B | vs MCK |
| NUSNu Skin Enterprises Inc. | 3.80 | +0.80% | $184.98M | vs MCK |
| ESYNEnerSyn Global Inc. | 1.11 | -0.89% | $37.44M | vs MCK |
| COSMCosmos Health Inc. | 2.81 | -2.09% | $14.14M | vs MCK |
| MEDSDataMeds AI Inc. | 1.34 | +84.14% | $7.67M | vs MCK |
| HKPDCellyan Biotechnology Co. Ltd Class A | 1.38 | +2.60% | $3.40M | vs MCK |
Indexes, lists and sector
McKesson stock FAQ
What is McKesson's stock price today?
MCK last traded at $1,069.43 as of Nov 20, 4:00 PM EST, up 0.68% on the day. Prices are delayed at least 15 minutes.
Does McKesson pay a dividend?
Yes. McKesson pays $3.40 per share annually, a 0.32% yield. The most recent dividend of $0.94 had an ex-dividend date of Sep 1, 2026.
What is MCK's P/E ratio?
MCK trades at a trailing P/E ratio of 27.58 and a forward P/E of 20.39, compared with a median of 18.9 for its closest peers.
Is McKesson in the S&P 500?
Yes. McKesson (MCK) is a constituent of the S&P 500 index.
Who is McKesson's CEO?
Mr. Brian S. Tyler Ph.D. is the chief executive officer of McKesson Corporation, which has about 41,600 employees.
Has MCK ever split its stock?
Yes. The most recent MCK stock split was a 2-for-1 split on Jan 5, 1998.
What is the MCK 52-week high?
The 52-week high for MCK is $1,121.50 and the 52-week low is $723.68. The stock is currently 4.6% below its high.